Julien Blouin

Stock Analyst at Goldman Sachs

(2.13)
# 2,929
Out of 5,147 analysts
28
Total ratings
42.86%
Success rate
-0.26%
Average return

Stocks Rated by Julien Blouin

UDR, Inc.
Jan 20, 2026
Maintains: Sell
Price Target: $33$38
Current: $37.50
Upside: -
Healthpeak Properties
Jan 9, 2026
Initiates: Neutral
Price Target: $17
Current: $17.68
Upside: -3.85%
Jones Lang LaSalle
Nov 26, 2025
Maintains: Buy
Price Target: $361$407
Current: $315.55
Upside: +28.98%
Camden Property Trust
Sep 17, 2025
Downgrades: Sell
Price Target: $118$106
Current: $108.34
Upside: -2.16%
American Homes 4 Rent
Sep 17, 2025
Downgrades: Neutral
Price Target: $43$37
Current: $30.00
Upside: +23.33%
Cushman & Wakefield
Aug 13, 2025
Maintains: Buy
Price Target: $18$20
Current: $13.41
Upside: +49.14%
Millrose Properties
May 15, 2025
Maintains: Buy
Price Target: $28$32
Current: $31.36
Upside: +0.45%
Invitation Homes
May 6, 2025
Maintains: Buy
Price Target: $39$43
Current: $26.34
Upside: +63.25%
Newmark Group
Mar 19, 2025
Maintains: Buy
Price Target: $20$17
Current: $14.52
Upside: +17.08%
Colliers International Group
Mar 19, 2025
Maintains: Neutral
Price Target: $165$145
Current: $118.73
Upside: +22.13%
Initiates: Buy
Price Target: $176
Current: $147.66
Upside: +19.19%
Initiates: Neutral
Price Target: $318
Current: $255.11
Upside: +24.65%
Initiates: Neutral
Price Target: $81
Current: $63.21
Upside: +28.14%
Initiates: Buy
Price Target: $187
Current: $133.86
Upside: +39.70%